Q1 2024 13F Holders as of 31 Mar 2024
-
Type / Class
-
Debt / NOTE 4.000%11/1
-
Market price (% of par)
-
83.07%
-
Total 13F principal
-
$208,792,404
-
Principal change
-
-$40,802,596
-
Total reported market value
-
$218,541,156
-
Number of holders
-
18
-
Value change
-
-$14,900,797,445
-
Number of buys
-
4
-
Number of sells
-
12
Institutional Holders of ESPERION THERAPEUTICS INC NE - NOTE 4.000%11/1 as of Q1 2024
As of 31 Mar 2024,
ESPERION THERAPEUTICS INC NE - NOTE 4.000%11/1 was held by
18 institutional
bondholders
reporting positions in Form 13F filings.
These institutions reported holding
$208,792,404
in principal (par value) of the bond.
The largest 10 bondholders included
PenderFund Capital Management Ltd., Davidson Kempner Capital Management LP, Pentwater Capital Management LP, Two Seas Capital LP, TENOR CAPITAL MANAGEMENT Co., L.P., HIGHBRIDGE CAPITAL MANAGEMENT LLC, WHITEBOX ADVISORS LLC, AMERIPRISE FINANCIAL INC, READYSTATE ASSET MANAGEMENT LP, and Point72 Asset Management, L.P..
This page lists
18
institutional bondholders reporting positions
for the Q1 2024 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price (% of par)
|
Principal |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.